세미나 및 이벤트
ES Cell Research - Present and Future (문신용 서울의대 교수
세미나 날짜
2005-04-29
작성자
권해선
작성일
2005-04-26
조회
1809
1. 제 목 : ES Cell Research - Present and Future
2. 연 사 : 문 신 용 교수 (세포응용연구 사업단 단장/서울의대 산부인과 교수)
3. 일 시 : 2005년 4월 29일 (금) 17:00-18:00
4. 장 소 : 서울대 신공학관(301동) 1512호 세미나실
한양대 공업센터 4층 세미나실 (화상강의로 진행)
5. 내 용 :
In the last several decades, investments in basic research have yielded extensive knowledge about the development of organism. Research on stem cells is advancing knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Scientists primarily work with two kinds of stem cells; embryonic stem cells and adult stem cells, which have different functions and characteristics.
More than 20years ago, stem cells from mouse embryos were derived. Since 1998, when human pluripotent stem cells were first isolated, research on stem cells has received much public attention. It has been hypothesized that stem cells may, at some point in the future, become the basis for treating diseases such as Parkinson"s disease, diabetes, and heart disease. In this sense, we call it the “Key to the Therapeutics of Chronic Diseases”. Animal stem cells will provide not only a helpful model for human disease but also a stable platform to develop new drugs in pharmaceutical companies. Although we cannot clearly foresee the end point of stem cell research, we are convinced that our effort will bear fruitful progress in future medicine.
Korean Stem Cell Research Center and Embryonic Stem Cell Bank, which would be supported by the Ministry of Science and Technology was established on July 1, 2002. Korean Embryonic Stem Cell Bank has established 36 embryonic stem cell lines and 1 cloned human embryonic stem cell line. The successful derivation of a human cloned ES cells opens the way for once-undreamed of treatments for long-term diseases such as diabetes, Parkinson"s and Alzheimer"s. With first breakthrough in "Therapeutic cloning", researchers work in order to bring ES cells into clinics.
There are many ways in which human stem cells can be used in basic research and in clinical research. However, there are many technical hurdles between the promise of stem cells and the realization of these uses, which will only be overcome by continued intensive stem cell research.
6. 약 력 :
1974 서울대학교 의과대학 의학과 졸업
1978 서울대학교 대학원 산부인과학 졸업
1987 서울대학교 대학원 산부인과학 졸업
1999 - 현재 서울대학교 인구의학연구소 소장
2002. 5 - 현재 과학기술부 2002년도 프론티어사업: 세포응용연구사업단 단장
7. 문 의 : 기계항공공학부 이정훈 교수 (☏880-9104) / 서울대 BK21 기계분야사업단 행정실 (☏880-7132)
8. 기계분야 박사과정 세미나 수업 수강생 여러분들은 필히 참석해 주시고,
기타 관심 있는 분들의 많은 참여를 부탁 드립니다.
2. 연 사 : 문 신 용 교수 (세포응용연구 사업단 단장/서울의대 산부인과 교수)
3. 일 시 : 2005년 4월 29일 (금) 17:00-18:00
4. 장 소 : 서울대 신공학관(301동) 1512호 세미나실
한양대 공업센터 4층 세미나실 (화상강의로 진행)
5. 내 용 :
In the last several decades, investments in basic research have yielded extensive knowledge about the development of organism. Research on stem cells is advancing knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Scientists primarily work with two kinds of stem cells; embryonic stem cells and adult stem cells, which have different functions and characteristics.
More than 20years ago, stem cells from mouse embryos were derived. Since 1998, when human pluripotent stem cells were first isolated, research on stem cells has received much public attention. It has been hypothesized that stem cells may, at some point in the future, become the basis for treating diseases such as Parkinson"s disease, diabetes, and heart disease. In this sense, we call it the “Key to the Therapeutics of Chronic Diseases”. Animal stem cells will provide not only a helpful model for human disease but also a stable platform to develop new drugs in pharmaceutical companies. Although we cannot clearly foresee the end point of stem cell research, we are convinced that our effort will bear fruitful progress in future medicine.
Korean Stem Cell Research Center and Embryonic Stem Cell Bank, which would be supported by the Ministry of Science and Technology was established on July 1, 2002. Korean Embryonic Stem Cell Bank has established 36 embryonic stem cell lines and 1 cloned human embryonic stem cell line. The successful derivation of a human cloned ES cells opens the way for once-undreamed of treatments for long-term diseases such as diabetes, Parkinson"s and Alzheimer"s. With first breakthrough in "Therapeutic cloning", researchers work in order to bring ES cells into clinics.
There are many ways in which human stem cells can be used in basic research and in clinical research. However, there are many technical hurdles between the promise of stem cells and the realization of these uses, which will only be overcome by continued intensive stem cell research.
6. 약 력 :
1974 서울대학교 의과대학 의학과 졸업
1978 서울대학교 대학원 산부인과학 졸업
1987 서울대학교 대학원 산부인과학 졸업
1999 - 현재 서울대학교 인구의학연구소 소장
2002. 5 - 현재 과학기술부 2002년도 프론티어사업: 세포응용연구사업단 단장
7. 문 의 : 기계항공공학부 이정훈 교수 (☏880-9104) / 서울대 BK21 기계분야사업단 행정실 (☏880-7132)
8. 기계분야 박사과정 세미나 수업 수강생 여러분들은 필히 참석해 주시고,
기타 관심 있는 분들의 많은 참여를 부탁 드립니다.
